Skip to main content
OpenTrials
Completed

NCT Number: NCT00224276

Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics

This pilot study hypothesizes that diagnosed and undiagnosed prevalence of diabetes mellitus may differ across antipsychotioc medications in a community mental health center. The study further hypothesizes that control of diabetes among diagnosed cases may be suboptimal.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Study of longitudinal incidence proved impractical within the limitations of the project.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients treated with antipsychotic medication at a community mental health center

Exclusion criteria

  • None

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • Janssen Pharmaceutica N.V., Belgium

Registry information

Official study title

Prevalence and Incidence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics

Important dates

First posted
Sep 22, 2005
Registry last updated
Sep 22, 2005

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.